Our Services

Comprehensive Clinical
Trial Services

From site selection to trial closeout, Research Reach INT delivers the operational infrastructure, regulatory expertise, and patient access that sponsors need to succeed.

01

Site Selection & Feasibility

Our site selection process combines proprietary database analytics, therapeutic area expertise, and on-the-ground investigator relationships to identify sites with the highest probability of enrollment success. We conduct rigorous feasibility assessments covering patient population, investigator experience, site infrastructure, and regulatory track record.

Key Capabilities

Protocol-specific site matching algorithm
Investigator qualification and track record review
Patient population density analysis
Infrastructure and technology readiness assessment
Competitive trial landscape evaluation
Feasibility survey design and management
Discuss This Service

02

Patient Recruitment & Retention

Enrollment delays are the leading cause of trial cost overruns. Our patient recruitment strategies combine digital outreach, physician referral networks, and community engagement to accelerate enrollment while maintaining strict protocol compliance. Our retention programs ensure patients remain engaged throughout the trial duration.

Key Capabilities

Digital and social media recruitment campaigns
Physician referral network activation
Pre-screening and eligibility optimization
Patient retention and engagement programs
Diversity and inclusion recruitment strategies
Enrollment tracking and real-time dashboards
Discuss This Service

03

Regulatory & Compliance Support

Navigating the regulatory landscape across multiple jurisdictions requires deep expertise and meticulous attention to detail. Our regulatory team provides comprehensive guidance from protocol development through final submission, ensuring your trial meets all applicable requirements.

Key Capabilities

IRB/IEC submission and management
ICH-GCP E6(R3) compliance implementation
FDA 21 CFR Part 11 compliance
EMA and local authority submissions
Audit preparation and inspection readiness
Protocol deviation management
Discuss This Service

04

Site Operations Management

Effective site operations are the backbone of a successful trial. Our site management team provides end-to-end operational oversight, from staff training and qualification through monitoring coordination and quality assurance, ensuring every site performs to the highest standards.

Key Capabilities

Site staff training and GCP certification
On-site and remote monitoring visits
Source document verification
Investigational product accountability
Quality management and CAPA systems
Sponsor and CRO liaison management
Discuss This Service

05

Data Management & Reporting

Data quality is non-negotiable in clinical research. Our data management team ensures robust data collection, rigorous EDC management, and real-time reporting that keeps sponsors fully informed at every milestone. We work with all major EDC platforms and maintain strict data integrity standards.

Key Capabilities

EDC setup, training, and management
Data query resolution and clean file management
Real-time enrollment and safety reporting
SAE reporting and pharmacovigilance support
Sponsor dashboard and KPI reporting
21 CFR Part 11 compliant systems
Discuss This Service

06

Trial Startup & Closeout

The first and last phases of a trial are often the most operationally intensive. Our startup specialists accelerate site activation through streamlined regulatory submissions, rapid contract execution, and efficient site initiation visits. Our closeout team ensures systematic database lock, archiving, and final reporting.

Key Capabilities

Accelerated site activation (target 4–6 weeks)
Contract and budget negotiation support
Site initiation visit coordination
Database lock and final data reconciliation
Regulatory archive preparation
Closeout visit and final report
Discuss This Service

FAQ

Frequently Asked Questions

A CRO (Contract Research Organization) typically manages the full clinical development process on behalf of a sponsor. An SMO like Research Reach INT focuses specifically on site management — we recruit, qualify, activate, and support investigator sites. We often work alongside CROs as a specialized site management partner, providing deeper site-level expertise and support than most CROs can offer in-house.
Yes. Our team has experience across all trial phases. Phase I trials require specialized early-phase units and intensive safety monitoring — we partner with qualified Phase I units in our network. Phase II–IV trials benefit from our broad investigator network and patient recruitment capabilities. We tailor our service model to the specific requirements of each phase.
Our target site activation timeline is 4–6 weeks from contract execution to first patient visit. This is achievable because we maintain pre-qualified investigator relationships, standardized contract templates, and a dedicated regulatory team. Actual timelines depend on protocol complexity, regulatory jurisdiction, and IRB/IEC review timelines.
Yes. Rare disease trials present unique challenges including small patient populations, specialized investigator requirements, and complex eligibility criteria. Our team includes specialists with rare disease experience who understand how to identify the right sites, engage patient advocacy groups, and design recruitment strategies that work within these constraints.

Ready to Discuss Your Trial Requirements?

Our team is ready to design a customized service package for your specific protocol and therapeutic area.

Request a Consultation

Confirm Action

Are you sure you want to perform this action?